Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs-Reference-Cited by-同舟云学术

Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs

Published:2013-04-25 Issue:9 Volume:22 Page:727-734
ISSN:2044-5415
Container-title:BMJ Quality & Safety
language:en
Short-container-title:BMJ Qual Saf

Author:

Kesselheim Aaron S,Franklin Jessica M,Avorn Jerry,Duke Jon D

Publisher

BMJ

Subject

Health Policy

Reference38 articles.

1. Department of Health and Human Services. Requirements on content and format of labeling for human prescription drug and biological products. 21 C.F.R. 201.56. Silver Spring, MD: US Food and Drug Administration, 2011.

2. Introduction to the new prescription drug labeling by the Food and Drug Administration;Lal;Am J Health Syst Pharm,2007

3. Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?;Busch;Psychiatr Serv,2010

4. Influence of physicians’ management and communication ability on patients’ persistence with antihypertensive medication;Tamblyn;Arch Intern Med,2010

5. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial;Weymiller;Arch Intern Med,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warning Labels as a Public Health Intervention: Effects and Challenges for Tobacco, Cannabis, and Opioid Medications;Annual Review of Public Health;2024-05-20

2. Improving drug safety with adverse event detection using natural language processing;Expert Opinion on Drug Safety;2023-07-03

4. Radical transparency in post-market oversight of medicine safety;BMJ;2022-10-05

5. Pharmacovigilance and Risk Communication for the Safe Use of Herbal and Traditional Medicines: How to Promote Evidence and Keep People Safe;Pharmacovigilance for Herbal and Traditional Medicines;2022